Accumulation of copy number alterations and clinical progression across advanced prostate cancer

被引：0
|
作者：
Emily Grist
Stefanie Friedrich
Christopher Brawley
Larissa Mendes
Marina Parry
Adnan Ali
Aine Haran
Alex Hoyle
Claire Gilson
Sharanpreet Lall
Leila Zakka
Carla Bautista
Alex Landless
Karolina Nowakowska
Anna Wingate
Daniel Wetterskog
A. M. Mahedi Hasan
Nafisah B. Akato
Malissa Richmond
Sofeya Ishaq
Nik Matthews
Anis A. Hamid
Christopher J. Sweeney
Matthew R. Sydes
Daniel M. Berney
Stefano Lise
Mahesh K. B. Parmar
Noel W. Clarke
Nicholas D. James
Paolo Cremaschi
Louise C. Brown
Gerhardt Attard
机构：
[1] Cancer Institute,
[2] University College London,undefined
[3] MRC Clinical Trials Unit at University College London,undefined
[4] GU Cancer Research/FASTMAN Group,undefined
[5] Manchester Cancer Institute,undefined
[6] The Christie and Salford Royal NHS Foundation Trusts,undefined
[7] The Institute of Cancer Research,undefined
[8] Imperial College,undefined
[9] Department of Medical Oncology,undefined
[10] Dana-Farber Cancer Institute,undefined
[11] Barts Cancer Institute,undefined
[12] Queen Mary University of London,undefined
[13] The Royal Marsden Hospital NHS Foundation Trust and The Institute of Cancer Research,undefined
来源：
Genome Medicine | / 14卷
关键词：
Advanced prostate cancer; Genomic biomarkers; Copy number alteration; STAMPEDE trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Progression in immunotherapy for advanced prostate cancer
    Liang, Hao
    Liu, Yang
    Guo, Jiao
    Dou, Maoyang
    Zhang, Xiaoyi
    Hu, Liyong
    Chen, Jun
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [32] Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma
    C Johnson
    KL Gorringe
    ER Thompson
    K Opeskin
    SE Boyle
    Y Wang
    P Hill
    GB Mann
    IG Campbell
    Hereditary Cancer in Clinical Practice, 10 (Suppl 2)
  • [33] Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma
    Johnson, Clint E.
    Gorringe, Kylie L.
    Thompson, Ella R.
    Opeskin, Ken
    Boyle, Samantha E.
    Wang, Yuker
    Hill, Prue
    Mann, G. Bruce
    Campbell, Ian G.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (03) : 889 - 898
  • [34] Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma
    Clint E. Johnson
    Kylie L. Gorringe
    Ella R. Thompson
    Ken Opeskin
    Samantha E. Boyle
    Yuker Wang
    Prue Hill
    G. Bruce Mann
    Ian G. Campbell
    Breast Cancer Research and Treatment, 2012, 133 : 889 - 898
  • [35] Detection of clinically relevant copy number alterations in oral cancer progression using multiplexed droplet digital PCR
    Hughesman, Curtis B.
    Lu, X. J. David
    Liu, Kelly Y. P.
    Zhu, Yuqi
    Towle, Rebecca M.
    Haynes, Charles
    Poh, Catherine F.
    SCIENTIFIC REPORTS, 2017, 7
  • [36] Detection of clinically relevant copy number alterations in oral cancer progression using multiplexed droplet digital PCR
    Curtis B. Hughesman
    X. J. David Lu
    Kelly Y. P. Liu
    Yuqi Zhu
    Rebecca M. Towle
    Charles Haynes
    Catherine F. Poh
    Scientific Reports, 7
  • [37] Copy number alterations: a catastrophic orchestration of the breast cancer genome
    Shahrouzi, Parastoo
    Forouz, Farzaneh
    Mathelier, Anthony
    Kristensen, Vessela N.
    Duijf, Pascal H. G.
    TRENDS IN MOLECULAR MEDICINE, 2024, 30 (08) : 750 - 764
  • [38] Bayesian detection of recurrent copy number alterations across multiple array samples
    Pique-Regi, Roger
    Monso-Varona, Jordi
    Ortega, Antonio
    Asgharzadeh, Shahab
    2008 IEEE INTERNATIONAL WORKSHOP ON GENOMIC SIGNAL PROCESSING AND STATISTICS, 2008, : 64 - +
  • [39] Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer
    Broderick, Amanda
    Pan, Elizabeth
    Li, Jinju
    Chu, Alec
    Hwang, Clara
    Barata, Pedro C.
    Cackowski, Frank Cameron
    Labriola, Matthew
    Ghose, Alyssa
    Bilen, Mehmet Asim
    Kilari, Deepak
    Thapa, Bicky
    Piero, Michael
    Graham, Laura
    Tripathi, Abhishek
    Garje, Rohan
    Koshkin, Vadim S.
    Hernandez, Erik
    Dorff, Tanya B.
    Schweizer, Michael Thomas
    Alva, Ajjai Shivaram
    McKay, Rana R.
    Armstrong, Andrew J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024,
  • [40] Prognostic and predictive role of tumor mutation burden and copy number alterations across metastatic cancer: Immunotherapeutic implications
    Tang, Xin-Ran
    Dong, Zhong Yi
    Wu, Dehua
    CANCER RESEARCH, 2019, 79 (13)
12345